The platform, which includes the new form factor CGM and the Simplera Sync sensor, is designed for integration with Medtronic ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Medtronic’s third quarter also marked a return to growth for its Diabetes unit in the United States, with the global adoption of the MiniMed 780G system driving performance. This trend is also ...

What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how ...

Medtronic: Long-Awaited FDA Approval of 780g Pump Should Return Diabetes Unit to Growth Wide-moat Medtronic received highly welcome news today as the U.S. Food and Drug Administration has (finally ...

Medtronic's business spans several therapeutic ... A few years ago, it launched the MiniMed 780G, an innovative insulin pump that can automatically adjust insulin delivery based on patients ...